Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
105,863,294
-
Total 13F shares
-
84,197,994
-
Share change
-
-4,315,100
-
Total reported value
-
$4,242,065,667
-
Put/Call ratio
-
132%
-
Price per share
-
$50.39
-
Number of holders
-
362
-
Value change
-
-$207,314,469
-
Number of buys
-
176
-
Number of sells
-
150
Institutional Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2024
As of 31 Dec 2024,
CORCEPT THERAPEUTICS INC - Common Stock (CORT) was held by
362 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
84,197,994 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, INGALLS & SNYDER LLC, RENAISSANCE TECHNOLOGIES LLC, Parallel Advisors, LLC, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, and JACOBS LEVY EQUITY MANAGEMENT, INC.
This page lists
362
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.